XML 38 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring charges and impairment charges (Tables)
 6 Months Ended
Jul. 01, 2018
Restructuring and Related Activities [Abstract]  
Restructuring and Other Impairment Charges
The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three and six months ended July 1, 2018 and July 2, 2017: 
Three Months Ended July 1, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (2)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
52,345

 
$
129

 
$
52,474

Other restructuring programs (1)
574

 
440

 
1,014

Restructuring charges
$
52,919

 
$
569

 
$
53,488

Long-lived asset impairment charge
—

 
1,865

 
1,865

Restructuring and impairment charges
$
52,919

 
$
2,434

 
$
55,353

Three Months Ended July 2, 2017
 
 
 
 
 
 
Termination benefits
 
Other costs (2)
 
Total
 
(Dollars in thousands)
Restructuring charges (3)
$
612

 
$
258

 
$
870

Six Months Ended July 1, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (2)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
52,345

 
$
129

 
$
52,474

2016 Footprint realignment plan
2,199

 
291

 
2,490

Other restructuring programs (4)
1,032

 
555

 
1,587

Restructuring charges
$
55,576

 
$
975

 
$
56,551

Long-lived asset impairment charge
—

 
1,865

 
1,865

Restructuring and impairment charges
$
55,576

 
$
2,840

 
$
58,416

Six Months Ended July 2, 2017
 
 
 
 
 
 
Termination benefits
 
Other costs (2)
 
Total
 
(Dollars in thousands)
Vascular Solutions integration program
$
4,853

 
$
34

 
$
4,887

2017 EMEA restructuring program
6,536

 
—

 
6,536

2016 Footprint realignment plan
825

 
76

 
901

Other restructuring programs (5)
1,147

 
344

 
1,491

Restructuring charges
$
13,361

 
$
454

 
$
13,815

(1)
Other restructuring programs include the 2016 and 2014 Footprint realignment plans, the Vascular Solutions integration program and the 2017 EMEA restructuring program as well as the other 2016 restructuring programs.
(2)
Other costs include facility closure, contract termination, and other exit costs.
(3)
Restructuring charges include charges related to the Vascular Solutions integration program, 2017 EMEA restructuring program, the 2016 and 2014 footprint realignment plans, the 2017 Pyng integration program and the 2016 Other Restructuring programs. The Company committed to the 2017 Pyng integration program, which relates to the integration of Pyng Medical Corp. (“Pyng”) into the Company, during the second quarter of 2017, following the Company’s acquisition of Pyng in April 2017.
(4) Other restructuring programs include the 2014 Footprint realignment plan, Vascular Solutions integration program, the 2017 EMEA restructuring program and the other 2016 restructuring programs.
(5) Other restructuring programs include the 2014 Footprint realignment plan, the 2017 Pyng integration program and the 2016 Other Restructuring programs.
Restructuring charges by reportable operating segment, and by all other operating segments in the aggregate, for the three and six months ended July 1, 2018 and July 2, 2017 are set forth in the following table:   
 
Three Months Ended
 
Six Months Ended
 
July 1, 2018
 
July 2, 2017
 
July 1, 2018
 
July 2, 2017
 
(Dollars in thousands)
Vascular North America
$
202

 
$
353

 
$
523

 
$
1,081

Interventional North America
362

 
191

 
907

 
4,406

Anesthesia North America
91

 
564

 
125

 
811

EMEA
52,539

 
(412
)
 
52,790

 
7,115

All other
294

 
174

 
2,206

 
402

Restructuring charges
$
53,488

 
$
870

 
$
56,551

 
$
13,815
Summary Of Current Cost Estimates By Major Type Of Cost Table
The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2018 Footprint realignment plan:
Type of expense
Total estimated amount expected to be incurred
Termination benefits
$60 million to $70 million
Other exit costs (1)
$2 million to $4 million
Restructuring charges
$62 million to $74 million
Restructuring related charges (2)
$40 million to $59 million
Total restructuring and restructuring related charges
$102 million to $133 million
(1)
Includes contract termination, facility closure, employee relocation, equipment relocation and outplacement costs.
(2)
Consists of pre-tax charges related to accelerated depreciation and other costs directly related to the plan, primarily project management costs and costs to transfer manufacturing operations to the new location, as well as a charge associated with the Company’s exit from the facilities that is expected to be imposed by the taxing authority in the affected jurisdiction. Excluding this tax charge, substantially all of the charges are expected to be recognized within costs of goods sold.